Literature DB >> 4040264

Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies.

H B Muss, R L Capizzi, J N Atkins, B L Powell, M R Cooper, D Ferree, R A McMahan, V Jobson, J Craig, H D Homesley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4040264

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  1 in total

1.  Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies.

Authors:  B L Powell; H B Muss; R L Capizzi; M E Caponera; D R White; P J Zekan; J N Atkins; D V Jackson; F Richards; J B Craig
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.